This groundbreaking book explores the suppressed science behind Vitamin B17 (Laetrile) found in apricot seeds and how it may hold the key to defeating cancer naturally.
World Without Cancer
G. Edward Griffin
1974
In World Without Cancer, G. Edward Griffin examines the compound laetrile (often associated with amygdalin, or vitamin B17, derived from apricot kernels) and advances the argument that cancer is fundamentally a deficiency disease rather than solely a genetic or environmental one. The book traces the history of laetrile’s promotion, legal battles surrounding its distribution, and debates within medical and regulatory institutions.
Griffin presents cancer not only as a medical issue but as a point of tension between independent researchers, patient advocates, regulatory agencies, and pharmaceutical economics. The text blends historical narrative, policy critique, and advocacy for alternative therapeutic approaches.
Rather than a clinical manual, the book functions as an investigative argument questioning prevailing treatment models and regulatory decisions of the 20th century.
“Whenever a disease becomes big business, questions about its cure inevitably extend beyond medicine into economics and power.”
Laetrile gained public attention in the 1950s–1970s as an alternative cancer treatment. During that period, it became the subject of court cases, state-level legalization efforts, federal enforcement actions, and scientific review. The U.S. Food and Drug Administration classified laetrile as an unapproved drug. As a result of regulatory rulings, laetrile was not incorporated into mainstream oncology practice. Griffin’s book became widely read within alternative health communities but was regarded skeptically within conventional medical institutions. The controversy itself contributed to the book’s reputation as oppositional to medical consensus, which limited its presence in academic and clinical settings.